ResMed CEO Mick Farrell spoke to MassDevice at AdvaMed’s annual meeting last week in Minneapolis about the company’s acquisitions and the challenges and triumphs ResMed has faced.
“Our primary goal is to show a really strong return from them, and they’re in 3 different areas. One of them was a double-down on China, where we now have a product that’s designed in China, made in China and sold for Chinese hospitals. In fact, Chinese hospitals can only buy domestic-made product. It was an investment in a segment that we really had never delved into before, and it took us from #2 to #1 market share in the Chinese market,” Farrell said.
